GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: FG-2101 is a non-hydroxamate antibacterial candidate designed to selectively inhibit bacterial UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) and it is one of the compounds claimed in Blacksmith Medicine's patent WO2023055686A1 [2]. FG-2101 is being developed for intravenous and oral routes of administration to treat Gram-negative bacteria infections. The name to structure was confirmed during the 'First Time disclosures' session at the ACS Spring 2025 meeting in San Diego.
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel